Check out our most popular compounded medications! Get Started
Bayview Pharmacy's Sodium Phosphate Dibasic Heptahydrate 0.9 Gm/5 ml/Sodium Phosphate Monobasic Monohydrate 2.4 Gm/5 ml Oral Solution is a liquid formulation intended for oral administration. This medication is used to treat conditions such as hypophosphatemia, hyperphosphatemia, renal failure, diarrhea, and constipation. It offers accurate dosing and convenient delivery, often utilized when a specific dosage strength or ease of swallowing is required.
Licensed to fill prescriptions for patients in RI, MA, CT, NY, NJ, NH, FL and ME.
Prescriber? Sign in or create an account for prescription details and order forms.
Bayview Pharmacy is pleased to provide a compounded oral solution of Sodium Phosphate Dibasic Heptahydrate 0.9 Gm/5 ml and Sodium Phosphate Monobasic Monohydrate 2.4 Gm/5 ml. This liquid formulation, consisting of these active ingredients dissolved in a suitable solvent, is intended for oral administration. It offers accurate dosing and convenient delivery of medication, often used when a specific dosage strength or ease of swallowing is required.
This formulation is utilized in the treatment of various disease states, including but not limited to hyperphosphatemia, hypophosphatemia, and metabolic acidosis. The combination of Sodium Phosphate Dibasic Heptahydrate and Sodium Phosphate Monobasic Monohydrate works to restore the body's electrolyte balance, a crucial factor for the proper functioning of the body's organs and systems. Additionally, this formulation is used to treat constipation by increasing the amount of water in the intestines, thereby softening stools and facilitating their passage.
For patients, this formulation is easy to administer and can be taken with or without food. It is crucial to adhere to the instructions provided by your healthcare provider when taking this medication. To prevent dehydration, it is also important to consume plenty of fluids while on this medication.
It is essential to closely monitor the patient's electrolyte levels while they are on this medication, as it can potentially cause electrolyte imbalances. Monitoring the patient's response to the medication is also crucial, as dosage adjustments may be necessary based on the patient's individual needs.
If you have any queries about this formulation or its application in treating various disease states, please do not hesitate to contact us at Bayview Pharmacy. We are committed to assisting you in finding the most suitable treatment options for your patients.
This Sodium Phosphate Dibasic Heptahydrate 0.9 Gm/5 ml/Sodium Phosphate Monobasic Monohydrate 2.4 Gm/5 ml Oral Solution is a liquid formulation designed for oral administration. It is primarily used to treat a range of conditions including constipation, electrolyte imbalances, and to increase urine output. Additionally, it can be used to manage hyperphosphatemia, hypocalcemia, and hypokalemia.
Patients should be aware that this formulation may cause side effects such as nausea, vomiting, and diarrhea. To prevent dehydration, it is crucial to maintain adequate fluid intake while on this medication. It's also important to note that this medication may interact with other drugs including antacids, diuretics, and laxatives. Therefore, it is essential to inform your healthcare provider about all the medications you are currently taking before starting this treatment.
Special caution should be exercised when prescribing this formulation to patients with kidney disease, as it can potentially exacerbate their condition. Regular monitoring of electrolyte levels is necessary in these patients. Additionally, signs of dehydration should be closely monitored due to the medication's potential to increase urine output.
If you have any queries or concerns about this formulation or its interaction with other medications, do not hesitate to contact your healthcare provider for further information and guidance.
Sodium Phosphate Dibasic Heptahydrate 0.9 Gm/5 ml/Sodium Phosphate Monobasic Monohydrate 2.4 Gm/5 ml Oral Solution is a compounded formulation that combines two distinct types of sodium phosphate salts. The Sodium Phosphate Dibasic Heptahydrate serves as a buffering agent, aiding in the maintenance of the solution's pH balance. On the other hand, Sodium Phosphate Monobasic Monohydrate functions as an osmotic laxative, assisting in stool softening and bowel movement promotion.
This unique combination of salts is primarily used in the treatment of constipation and fecal impaction, as well as in the preparation of the bowel for certain medical procedures. When administered orally, the solution operates by drawing water into the intestines, which aids in stool softening and encourages bowel movements. It is crucial to consume ample fluids while on this medication to prevent dehydration.
The medication is available in a 5 ml oral solution format and should be taken as directed by a healthcare professional. It is vital to adhere to the instructions meticulously and avoid exceeding the recommended dosage. If there are any queries regarding the administration of this medication, it is advisable to consult with a healthcare professional.
The Sodium Phosphate Dibasic Heptahydrate 0.9 Gm/5 ml/Sodium Phosphate Monobasic Monohydrate 2.4 Gm/5 ml Oral Solution is a liquid formulation designed for oral administration. This formulation is composed of one or more active ingredients dissolved in a suitable solvent, ensuring accurate dosing and convenient delivery of medication. It is often utilized when a specific dosage strength or ease of swallowing is required.
It can be used to treat patients suffering from metabolic acidosis, a condition characterized by excessive acidity in the blood and body tissues. Additionally, it is beneficial for those with hypomagnesemia, a condition marked by low levels of magnesium in the blood.
Patients with hypocalcemia, a condition characterized by low levels of calcium in the blood, can also benefit from this formulation.
This formulation is also beneficial for patients with hypernatremia, a condition characterized by high levels of sodium in the blood, and those with hypercalcemia, a condition marked by high levels of calcium in the blood. It can also be used to treat patients with hyponatremia, a condition characterized by low levels of sodium in the blood, and those with hypermagnesemia, a condition marked by high levels of magnesium in the blood.
Lastly, this formulation can be used to treat patients with hyperkalemia, a condition characterized by high levels of potassium in the blood, and those with hyperuricemia, a condition marked by high levels of uric acid in the blood. If you have any questions about the use of this formulation for any of these conditions, please reach out for further information.
This is a liquid formulation that contains Sodium Phosphate Dibasic Heptahydrate and Sodium Phosphate Monobasic Monohydrate as active ingredients. It is intended for oral administration and is often used when a specific dosage strength or ease of swallowing is required.
This formulation is used to deliver medication in a precise dosage. It is often used when the patient has difficulty swallowing pills or when a specific dosage strength is required.
This medication should be stored in a cool, dry place, away from direct sunlight. Always keep the container tightly closed when not in use.
If you miss a dose, take it as soon as you remember. If it is close to the time for your next dose, skip the missed dose and go back to your normal time. Do not take two doses at the same time or extra doses.
Like all medications, this formulation can cause side effects, although not everybody gets them. Common side effects may include nausea, vomiting, stomach pain, or diarrhea. If you experience any severe or persistent side effects, contact your healthcare provider immediately.
Always inform your healthcare provider about all the medicines you are currently taking, including over-the-counter drugs and herbal supplements, to avoid any potential drug interactions.
If you are pregnant, planning to become pregnant, or breastfeeding, consult your healthcare provider before taking this medication.
This medication should be taken orally as directed by your healthcare provider. The dosage is based on your medical condition and response to treatment.
If you suspect an overdose, contact a poison control center or emergency room immediately. Symptoms of overdose may include severe nausea, vomiting, or diarrhea.
This medication can be given to children, but the dosage must be adjusted according to their weight and age. Always consult with a healthcare provider before giving any medication to a child.
This formulation is compounded by Bayview Pharmacy on a prescriber's order for an individual patient. It is not an FDA-approved drug product, and the FDA has not evaluated it for safety, effectiveness, or manufacturing quality.
The conditions listed on this page are indications prescribers have ordered this preparation for. They are not FDA-approved indications, and listing them is not a statement that this preparation is effective for them.
A valid prescription is required. Availability depends on Bayview's licensure in your state. This page is general information, not medical advice — discuss your situation with a licensed healthcare provider.
Search by NCPDP 4106882, or by name and ZIP: Bayview Pharmacy, Warwick, RI 02886. Select it as the destination pharmacy and save it as a favorite. Click any value to copy it.
Compounded preparations have no NDC, so this formula will not appear in your EHR's drug search. Use your system's compound, non-formulary, or free-text prescription entry and name the preparation exactly as written in step 3. If your EHR forces you to pick a listed drug, pick the closest entry for the active ingredient and put the full formula in the prescription body (the Sig or directions field), not in Notes to Pharmacy.
Compounded preparations have no NDC and will not appear in your drug search. For EPCS to validate, select a drug entry your EHR recognizes as controlled, usually the bulk powder entry for the active ingredient (for example Ketamine (bulk) powder, not a branded product), then put the full formula from step 3 in the prescription body. A free-text entry that does not validate as controlled will be rejected by your EPCS module.
Quantity and directions are starting points for this dose form, not treatment recommendations. Dosing remains the prescriber's responsibility.
Transmit from your EHR. For this non-controlled preparation we also accept fax to (401) 284-4506 and phoned orders at (401) 284-4505. Order forms are on the formulation pages and in the prescriber portal.
Transmit with two-factor authentication through your EPCS-enabled EHR. No order form is offered for this preparation; e-prescribing guides for our controlled preparations are on the formulation pages.
Licensed to dispense in RI, MA, CT, NY, NJ, NH, FL, and ME. Compounded preparations are not FDA-approved. A valid prescription is required. Full guide, including steps by EHR: How to e-prescribe to Bayview. Questions about this formula: call (401) 284-4505.
Take orally
